Syntenin-1 (Syndecan-binding protein 1) PDZ2 domain (SDCBP PDZ2)

Syntenin-1, also known as Syndecan-binding protein 1 (SDCBP) or Melanoma differentiation-associated gene 9 (MDA-9), is a multifunctional scaffold protein characterized by two tandem PDZ domains, with the PDZ2 domain being a critical site for high-affinity protein-protein interactions [UniProt, 2024]. It plays a central role in the biogenesis of exosomes through the Syntenin-ALIX pathway and regulates the trafficking of various transmembrane proteins, including syndecans and tetraspanins [Baietti et al., 2012, Nature]. In oncology, Syntenin-1 is frequently overexpressed and acts as a potent driver of tumor progression, epithelial-mesenchymal transition (EMT), and metastasis by activating signaling cascades such as Src, FAK, and p38 MAPK [Kegelman et al., 2017, Pharmacology & Therapeutics]. The PDZ2 domain specifically facilitates these oncogenic functions by binding to the C-terminal motifs of partner proteins, making it a primary target for therapeutic intervention. Small molecule inhibitors like MS-118 have been developed to occupy the PDZ2 binding pocket, effectively reducing tumor growth and metastatic potential in preclinical models [Pradhan et al., 2020, Cancer Research]. Beyond cancer, the PDZ2 domain is also involved in viral entry and budding, suggesting broader therapeutic applications in infectious diseases [Groot et al., 2003, Journal of Biological Chemistry]. However, the high structural homology among the PDZ domain family presents a significant challenge for achieving the selectivity required to avoid systemic toxicity. Current research focuses on refining the specificity of these inhibitors to disrupt pathological signaling while sparing essential cellular scaffolding functions.

Other names

Melanoma differentiation-associated gene 9 (MDA-9)Syntenin-1SDCBPTACIP18Syndecan-binding protein 1 PDZ2 domain

Inhibition of PDZ domain-mediated protein-protein interactions by competitively binding to the PDZ2 hydrophobic pocket, thereby preventing the assembly of pro-metastatic signaling complexes and exosome secretion.